Increasing average concentrations of sotatercept improved 6-minute walk distance, pulmonary vascular resistance, and levels of NT-proBNP.
In the era of DOACs, risk for CTEPH following pulmonary embolism is affected by multiple factors, including gender and heart load.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback